MTMR3
Basic information
Region (hg38): 22:29883169-30030868
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTMR3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 54 | 55 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 54 | 2 | 1 |
Variants in MTMR3
This is a list of pathogenic ClinVar variants found in the MTMR3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-29978987-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
22-29979012-A-G | not specified | Uncertain significance (Apr 11, 2023) | ||
22-29979047-G-C | not specified | Uncertain significance (Oct 06, 2022) | ||
22-29991557-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
22-29991559-G-C | not specified | Uncertain significance (Nov 22, 2022) | ||
22-30007207-G-T | not specified | Uncertain significance (Sep 01, 2021) | ||
22-30007233-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
22-30007239-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
22-30007242-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
22-30007267-G-T | not specified | Uncertain significance (Jun 29, 2022) | ||
22-30007290-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
22-30007315-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
22-30007318-C-T | Likely benign (Feb 01, 2023) | |||
22-30007949-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
22-30007952-A-G | not specified | Uncertain significance (Jun 11, 2021) | ||
22-30013528-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
22-30016534-C-T | Likely benign (Feb 01, 2023) | |||
22-30016646-G-A | not specified | Uncertain significance (Feb 12, 2024) | ||
22-30017981-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
22-30017999-A-G | not specified | Uncertain significance (Sep 29, 2023) | ||
22-30018065-C-G | not specified | Uncertain significance (Mar 19, 2024) | ||
22-30018071-C-T | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Dec 17, 2024) | ||
22-30019542-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
22-30019582-G-T | not specified | Uncertain significance (May 08, 2023) | ||
22-30019592-C-T | not specified | Uncertain significance (Aug 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTMR3 | protein_coding | protein_coding | ENST00000401950 | 18 | 147712 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000627 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.00 | 524 | 669 | 0.783 | 0.0000373 | 7858 |
Missense in Polyphen | 198 | 320.55 | 0.6177 | 3761 | ||
Synonymous | 0.0182 | 253 | 253 | 0.999 | 0.0000144 | 2335 |
Loss of Function | 6.17 | 9 | 61.0 | 0.148 | 0.00000336 | 656 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000146 | 0.000146 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000571 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.0000571 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphatase that acts on lipids with a phosphoinositol headgroup. Has phosphatase activity towards phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate. May also dephosphorylate proteins phosphorylated on Ser, Thr, and Tyr residues (PubMed:10733931). {ECO:0000269|PubMed:10733931, ECO:0000269|PubMed:11676921}.;
- Pathway
- Inositol phosphate metabolism - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Metabolism of lipids;3-phosphoinositide degradation;Metabolism;D-<i>myo</i>-inositol-5-phosphate metabolism;superpathway of inositol phosphate compounds;Macroautophagy;Cellular responses to external stimuli;Synthesis of PIPs at the plasma membrane;PI Metabolism;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.0122
- rvis_EVS
- -0.9
- rvis_percentile_EVS
- 10.16
Haploinsufficiency Scores
- pHI
- 0.241
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.102
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtmr3
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;phosphatidylinositol biosynthetic process;macroautophagy;peptidyl-tyrosine dephosphorylation;cellular response to glucose starvation;phosphatidylinositol dephosphorylation;regulation of phosphatidylinositol dephosphorylation;phosphatidylinositol 5-phosphate metabolic process;regulation of autophagosome assembly
- Cellular component
- cytoplasm;cytosol;membrane;extrinsic component of membrane
- Molecular function
- phosphatidylinositol-3-phosphatase activity;protein serine/threonine phosphatase activity;protein tyrosine phosphatase activity;protein binding;protein phosphatase binding;metal ion binding;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity